tetraethylammonium has been researched along with Deafness in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Deafness: A general term for the complete loss of the ability to hear from both ears.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meşe, G | 1 |
Valiunas, V | 1 |
Brink, PR | 1 |
White, TW | 1 |
Hibino, H | 1 |
Horio, Y | 1 |
Inanobe, A | 1 |
Doi, K | 1 |
Ito, M | 1 |
Yamada, M | 1 |
Gotow, T | 1 |
Uchiyama, Y | 1 |
Kawamura, M | 1 |
Kubo, T | 1 |
Kurachi, Y | 1 |
2 other studies available for tetraethylammonium and Deafness
Article | Year |
---|---|
Connexin26 deafness associated mutations show altered permeability to large cationic molecules.
Topics: Cell Line; Connexin 26; Connexins; Cyclic AMP; Deafness; Ethidium; Gap Junctions; Humans; Ion Channe | 2008 |
An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential.
Topics: 4-Aminopyridine; Action Potentials; Aging; Animals; Barium; Cochlear Duct; Deafness; DNA Primers; En | 1997 |